WO2006101237A1 - Recipient de stockage par congelation et procede pour sa fabrication - Google Patents
Recipient de stockage par congelation et procede pour sa fabrication Download PDFInfo
- Publication number
- WO2006101237A1 WO2006101237A1 PCT/JP2006/306183 JP2006306183W WO2006101237A1 WO 2006101237 A1 WO2006101237 A1 WO 2006101237A1 JP 2006306183 W JP2006306183 W JP 2006306183W WO 2006101237 A1 WO2006101237 A1 WO 2006101237A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fluorine
- group
- adhesive
- film
- containing polymer
- Prior art date
Links
- 238000003860 storage Methods 0.000 title claims abstract description 16
- 238000000034 method Methods 0.000 title description 46
- 230000008569 process Effects 0.000 title description 9
- 230000001070 adhesive effect Effects 0.000 claims abstract description 163
- 239000000853 adhesive Substances 0.000 claims abstract description 162
- 229910052731 fluorine Inorganic materials 0.000 claims description 188
- 239000011737 fluorine Substances 0.000 claims description 172
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 claims description 164
- 239000000178 monomer Substances 0.000 claims description 97
- 238000005138 cryopreservation Methods 0.000 claims description 90
- 229920006254 polymer film Polymers 0.000 claims description 61
- 229920005989 resin Polymers 0.000 claims description 44
- 239000011347 resin Substances 0.000 claims description 44
- 125000004432 carbon atom Chemical group C* 0.000 claims description 43
- 229920001721 polyimide Polymers 0.000 claims description 42
- 229920001577 copolymer Polymers 0.000 claims description 39
- 239000004642 Polyimide Substances 0.000 claims description 38
- -1 perfluoro (vinylmethyl) Chemical group 0.000 claims description 33
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 31
- 239000000126 substance Substances 0.000 claims description 31
- 125000000524 functional group Chemical group 0.000 claims description 28
- 229920000642 polymer Polymers 0.000 claims description 26
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 24
- 125000001153 fluoro group Chemical group F* 0.000 claims description 23
- 238000004519 manufacturing process Methods 0.000 claims description 21
- 125000002947 alkylene group Chemical group 0.000 claims description 16
- 238000007789 sealing Methods 0.000 claims description 16
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 238000007710 freezing Methods 0.000 claims description 12
- 230000008014 freezing Effects 0.000 claims description 12
- 239000005977 Ethylene Substances 0.000 claims description 10
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 125000005843 halogen group Chemical group 0.000 claims description 10
- HCDGVLDPFQMKDK-UHFFFAOYSA-N hexafluoropropylene Chemical group FC(F)=C(F)C(F)(F)F HCDGVLDPFQMKDK-UHFFFAOYSA-N 0.000 claims description 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 9
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 9
- 125000003700 epoxy group Chemical group 0.000 claims description 9
- 125000000542 sulfonic acid group Chemical group 0.000 claims description 9
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 7
- BQCIDUSAKPWEOX-UHFFFAOYSA-N 1,1-Difluoroethene Chemical compound FC(F)=C BQCIDUSAKPWEOX-UHFFFAOYSA-N 0.000 claims description 6
- 239000004699 Ultra-high molecular weight polyethylene Substances 0.000 claims description 6
- 229920000785 ultra high molecular weight polyethylene Polymers 0.000 claims description 6
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 5
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 5
- 239000005038 ethylene vinyl acetate Substances 0.000 claims description 5
- 125000005702 oxyalkylene group Chemical group 0.000 claims description 5
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims description 5
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 5
- CJENPNUXCMYXPT-UHFFFAOYSA-N 1-chloro-1,2-difluoroethene Chemical group FC=C(F)Cl CJENPNUXCMYXPT-UHFFFAOYSA-N 0.000 claims description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 45
- 239000007788 liquid Substances 0.000 abstract description 24
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 22
- 229920002313 fluoropolymer Polymers 0.000 abstract description 16
- 239000004811 fluoropolymer Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 abstract description 6
- 241000700605 Viruses Species 0.000 abstract description 6
- 238000011109 contamination Methods 0.000 abstract description 6
- 238000010257 thawing Methods 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 30
- 210000004027 cell Anatomy 0.000 description 19
- 239000012472 biological sample Substances 0.000 description 17
- 238000001125 extrusion Methods 0.000 description 17
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
- 238000007334 copolymerization reaction Methods 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 15
- 238000002844 melting Methods 0.000 description 13
- 230000008018 melting Effects 0.000 description 13
- 238000006116 polymerization reaction Methods 0.000 description 13
- 238000000465 moulding Methods 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 9
- 238000003475 lamination Methods 0.000 description 9
- 125000005587 carbonate group Chemical group 0.000 description 8
- 239000000306 component Substances 0.000 description 8
- 239000011368 organic material Substances 0.000 description 8
- 230000006378 damage Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 125000001931 aliphatic group Chemical group 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 6
- 229910052782 aluminium Inorganic materials 0.000 description 6
- 235000013601 eggs Nutrition 0.000 description 6
- 238000010030 laminating Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 5
- 239000012503 blood component Substances 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 210000002381 plasma Anatomy 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 5
- 239000004810 polytetrafluoroethylene Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000001772 blood platelet Anatomy 0.000 description 4
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 4
- 150000001735 carboxylic acids Chemical class 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 238000000748 compression moulding Methods 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 210000003958 hematopoietic stem cell Anatomy 0.000 description 4
- 239000011229 interlayer Substances 0.000 description 4
- 229920005604 random copolymer Polymers 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 238000002788 crimping Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 238000003898 horticulture Methods 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000003505 polymerization initiator Substances 0.000 description 3
- 230000000379 polymerizing effect Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 238000007790 scraping Methods 0.000 description 3
- 238000000807 solvent casting Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000009823 thermal lamination Methods 0.000 description 3
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- AYKYXWQEBUNJCN-UHFFFAOYSA-N 3-methylfuran-2,5-dione Chemical compound CC1=CC(=O)OC1=O AYKYXWQEBUNJCN-UHFFFAOYSA-N 0.000 description 2
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 description 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 239000012790 adhesive layer Substances 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 210000002798 bone marrow cell Anatomy 0.000 description 2
- IAQRGUVFOMOMEM-UHFFFAOYSA-N but-2-ene Chemical compound CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- UUAGAQFQZIEFAH-UHFFFAOYSA-N chlorotrifluoroethylene Chemical compound FC(F)=C(F)Cl UUAGAQFQZIEFAH-UHFFFAOYSA-N 0.000 description 2
- HNEGQIOMVPPMNR-IHWYPQMZSA-N citraconic acid Chemical compound OC(=O)C(/C)=C\C(O)=O HNEGQIOMVPPMNR-IHWYPQMZSA-N 0.000 description 2
- 229940018557 citraconic acid Drugs 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- BXKDSDJJOVIHMX-UHFFFAOYSA-N edrophonium chloride Chemical compound [Cl-].CC[N+](C)(C)C1=CC=CC(O)=C1 BXKDSDJJOVIHMX-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000010292 electrical insulation Methods 0.000 description 2
- 210000004700 fetal blood Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- XUCNUKMRBVNAPB-UHFFFAOYSA-N fluoroethene Chemical compound FC=C XUCNUKMRBVNAPB-UHFFFAOYSA-N 0.000 description 2
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 239000011261 inert gas Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000005001 laminate film Substances 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 2
- 239000002120 nanofilm Substances 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- KDGNCLDCOVTOCS-UHFFFAOYSA-N (2-methylpropan-2-yl)oxy propan-2-yl carbonate Chemical compound CC(C)OC(=O)OOC(C)(C)C KDGNCLDCOVTOCS-UHFFFAOYSA-N 0.000 description 1
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- LFKIWESNALQTIC-UHFFFAOYSA-N 1,1,2,2,3,3-hexafluoro-3-(1,2,2-trifluoroethenoxy)propan-1-ol Chemical compound OC(F)(F)C(F)(F)C(F)(F)OC(F)=C(F)F LFKIWESNALQTIC-UHFFFAOYSA-N 0.000 description 1
- MIZLGWKEZAPEFJ-UHFFFAOYSA-N 1,1,2-trifluoroethene Chemical group FC=C(F)F MIZLGWKEZAPEFJ-UHFFFAOYSA-N 0.000 description 1
- FRCHKSNAZZFGCA-UHFFFAOYSA-N 1,1-dichloro-1-fluoroethane Chemical compound CC(F)(Cl)Cl FRCHKSNAZZFGCA-UHFFFAOYSA-N 0.000 description 1
- BEQKKZICTDFVMG-UHFFFAOYSA-N 1,2,3,4,6-pentaoxepane-5,7-dione Chemical compound O=C1OOOOC(=O)O1 BEQKKZICTDFVMG-UHFFFAOYSA-N 0.000 description 1
- SOZFIIXUNAKEJP-UHFFFAOYSA-N 1,2,3,4-tetrafluorobenzene Chemical compound FC1=CC=C(F)C(F)=C1F SOZFIIXUNAKEJP-UHFFFAOYSA-N 0.000 description 1
- APQOMSCEPGHMDB-UHFFFAOYSA-N 2,2,3,3-tetrafluoro-3-(1,2,2-trifluoroethenoxy)propanoic acid Chemical compound OC(=O)C(F)(F)C(F)(F)OC(F)=C(F)F APQOMSCEPGHMDB-UHFFFAOYSA-N 0.000 description 1
- SJGGAMMXIZFWSF-UHFFFAOYSA-N 2,3,3-trifluoroprop-2-enoyl fluoride Chemical compound FC(F)=C(F)C(F)=O SJGGAMMXIZFWSF-UHFFFAOYSA-N 0.000 description 1
- DIOZVWSHACHNRT-UHFFFAOYSA-N 2-(2-prop-2-enoxyethoxy)ethanol Chemical compound OCCOCCOCC=C DIOZVWSHACHNRT-UHFFFAOYSA-N 0.000 description 1
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 1
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- WOLRBLILVRYDQP-UHFFFAOYSA-N 2-(trifluoromethyl)prop-2-enoyl fluoride Chemical compound FC(=O)C(=C)C(F)(F)F WOLRBLILVRYDQP-UHFFFAOYSA-N 0.000 description 1
- GYIYNNBYDCPYEG-UHFFFAOYSA-N 2-carboxyoxycarbonyloxyacetic acid Chemical compound OC(=O)COC(=O)OC(O)=O GYIYNNBYDCPYEG-UHFFFAOYSA-N 0.000 description 1
- LWCDSJZGNUDNCO-UHFFFAOYSA-N 2-fluorobut-2-enoic acid Chemical compound CC=C(F)C(O)=O LWCDSJZGNUDNCO-UHFFFAOYSA-N 0.000 description 1
- TYCFGHUTYSLISP-UHFFFAOYSA-N 2-fluoroprop-2-enoic acid Chemical compound OC(=O)C(F)=C TYCFGHUTYSLISP-UHFFFAOYSA-N 0.000 description 1
- QMIWYOZFFSLIAK-UHFFFAOYSA-N 3,3,3-trifluoro-2-(trifluoromethyl)prop-1-ene Chemical compound FC(F)(F)C(=C)C(F)(F)F QMIWYOZFFSLIAK-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004697 Polyetherimide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 108700042768 University of Wisconsin-lactobionate solution Proteins 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 125000004018 acid anhydride group Chemical group 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229920005603 alternating copolymer Polymers 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 238000012661 block copolymerization Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- 238000012411 cloning technique Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 229920003020 cross-linked polyethylene Polymers 0.000 description 1
- 239000004703 cross-linked polyethylene Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- XNMQEEKYCVKGBD-UHFFFAOYSA-N dimethylacetylene Natural products CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 125000002573 ethenylidene group Chemical group [*]=C=C([H])[H] 0.000 description 1
- 229920000840 ethylene tetrafluoroethylene copolymer Polymers 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000005462 imide group Chemical group 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000009863 impact test Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 230000005499 meniscus Effects 0.000 description 1
- HNEGQIOMVPPMNR-NSCUHMNNSA-N mesaconic acid Chemical compound OC(=O)C(/C)=C/C(O)=O HNEGQIOMVPPMNR-NSCUHMNNSA-N 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 1
- HNEGQIOMVPPMNR-UHFFFAOYSA-N methylfumaric acid Natural products OC(=O)C(C)=CC(O)=O HNEGQIOMVPPMNR-UHFFFAOYSA-N 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 125000003355 oxamoyl group Chemical group C(C(=O)N)(=O)* 0.000 description 1
- 125000005429 oxyalkyl group Chemical group 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical compound CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- 229920009441 perflouroethylene propylene Polymers 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 210000004623 platelet-rich plasma Anatomy 0.000 description 1
- 229920003223 poly(pyromellitimide-1,4-diphenyl ether) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920001601 polyetherimide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000003761 preservation solution Substances 0.000 description 1
- HJBYJZCUFFYSGA-UHFFFAOYSA-N prop-2-enoyl fluoride Chemical compound FC(=O)C=C HJBYJZCUFFYSGA-UHFFFAOYSA-N 0.000 description 1
- RGBXDEHYFWDBKD-UHFFFAOYSA-N propan-2-yl propan-2-yloxy carbonate Chemical compound CC(C)OOC(=O)OC(C)C RGBXDEHYFWDBKD-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- YPVDWEHVCUBACK-UHFFFAOYSA-N propoxycarbonyloxy propyl carbonate Chemical compound CCCOC(=O)OOC(=O)OCCC YPVDWEHVCUBACK-UHFFFAOYSA-N 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000005060 rubber Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- XTVMZZBLCLWBPM-UHFFFAOYSA-N tert-butylcyclohexane Chemical compound CC(C)(C)C1CCCCC1 XTVMZZBLCLWBPM-UHFFFAOYSA-N 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 229920006259 thermoplastic polyimide Polymers 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
- A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
- A01N1/147—Carriers for immersion in cryogenic fluid for slow freezing or vitrification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
- A61B10/0096—Casings for storing test samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/42—Low-temperature sample treatment, e.g. cryofixation
Definitions
- the present invention relates to a cryopreservation container and a method for producing the same.
- a cryopreservation container comprising at least an adhesive fluorine-containing polymer film, preferably a laminate film including at least an adhesive fluorine-containing polymer film and a cold-resistant resin film, the laminate film.
- the invention relates to a cryopreservation container in which at least one surface of the film is an adhesive fluorine-containing polymer film.
- blood, rare cells, living tissues, and the like are stored at a cryogenic temperature of about 80 to 196 ° C.
- rare cells such as bone marrow cells and hematopoietic stem cells are effective in treating intractable diseases such as leukemia, and long-term storage techniques are required.
- cryopreservation containers used for storage for example, polypropylene-made needles are commercially available at the laboratory level, and are inexpensive and easy to handle.
- Patent Document 1 discloses a film having a laminated film strength of a polyimide film and a fluorinated ethylene propylene polymer film (Patent Document 1), a film having a film power of a copolymer of tetrafluoroethylene and ethylene (Patent Document 2), etc.
- Patent Document 3 discloses a cryopreservation container formed of a film of an ethylene vinyl acetate copolymer that has been biaxially stretched by electron beam irradiation.
- Patent Document 4 discloses a cryopreservation container formed of a biaxially stretched crosslinked polyethylene film.
- the fluorocarbon resins disclosed in Patent Documents 1 and 2 are required to be manufactured by heat sealing at a high temperature with a high melting point. Despite being manufactured under the conditions, the seal strength is weak, so it often breaks during cryopreservation.
- the stretched film disclosed in Patent Documents 3 and 4 is heat sealed. The film shrinks and wrinkles in the seal area and its surroundings due to the operation, and in actual use, it may often be damaged by rough handling.
- the adhesive layer may harden during low-temperature storage, and the laminated film may peel off, making it suitable as a cryopreservation container. It is not a thing.
- ultrahigh molecular weight polyethylene is very excellent in that it is impact resistant, abrasion resistant, self-swelling, chemical resistant, cold resistant and non-toxic, but it is extremely high !, melt viscosity Therefore, the film production method is usually made by cutting a powdery raw material resin into a block-shaped product by compression molding or the like.
- the molding force is not easy.
- polyethylene on the surface of the film may fall off if there is a paste, and if used as a medical bag, it may cause contamination.
- compression molding air is taken in at the time of molding, and pinholes may occur in the film cut in the next process.
- the molecular weight of ultra-high molecular weight polyethylene is as high as 1 million or more, so the fluidity of polyethylene molecular chains is poor. Therefore, there is a problem in stable production of containers that are difficult to heat seal.
- Patent Document 1 Japanese Patent Publication No.49-008079
- Patent Document 2 Japanese Utility Model Publication No. 55-055069
- Patent Document 3 Japanese Patent Publication No. 55-044977
- Patent Document 4 Japanese Patent Publication No. 62-057351
- Patent Document 5 Japanese Patent Laid-Open No. 7-246230 Disclosure of the invention
- the present inventors propose to use an adhesive fluorine-containing polymer film for a cryopreservation container.
- Adhesive fluorine-containing polymer film is composed of a fluorine-containing polymer having an adhesive site
- the cryopreservation container according to [2] which is at least one selected from the group consisting of:
- the adhesive fluorine-containing polymer has a reactive functional group as an adhesive site, and is a copolymer obtained by copolymerizing the following (A) and (B): [3] Described cryopreservation container:
- X 1 and X 2 are each a hydrogen atom or a halogen atom
- Y is a hydrogen atom, a fluorine atom, a fluorine-containing alkyl group having 1 to 5 carbon atoms or a fluorine-containing alkyl group having 1 to 5 carbon atoms. Is a alkyl group
- a fluorine-containing monomer having a reactive functional group is represented by the following formula (2) [4] to [
- X 1 and X 2 are each a hydrogen atom or a halogen atom
- Z is a hydroxyl group, a carboxyl group, a cyano group, a sulfonic acid group or an epoxy group
- R is a carbon number f.
- ⁇ 1 and ⁇ are each a hydrogen atom or a halogen atom
- ⁇ 1 and ⁇ 2 are a hydrogen atom, a fluorine atom, a fluorine-containing alkyl group having 1 to 5 carbon atoms, or a fluorine-containing group having 1 to 5 carbon atoms, respectively.
- ⁇ is a hydroxyl group, a carboxyl group, a cyano group
- R is a fluorine-containing alkylene group having 1 to 40 carbon atoms
- a fluorine-containing oxyalkylene group having 1 to 40 carbon atoms or a fluorine-containing alkylene group having at least one ether bond having 1 to 40 carbon atoms, and (1 + m) Zn force is 2000
- the adhesive fluorine-containing polymer has a fluorine-containing monomer unit derived from a fluorine-containing monomer and a fluorine-free monomer unit derived from a fluorine-free monomer.
- the cold-resistant resin is at least one selected from the group consisting of ultrahigh molecular weight polyethylene, polyimide, polytetrafluoroethylene, ethylene-tetrafluoroethylene copolymer, and ethylene acetate butyl copolymer
- a method for producing a cryopreservation container wherein at least an adhesive fluorine-containing polymer film is formed into a bag shape by heat sealing,
- a laminated film including at least an adhesive fluorine-containing polymer film and a film other than the adhesive fluorine-containing polymer film, wherein the adhesive fluorine-containing polymer film is present on at least one outermost surface is heated.
- the present invention relates to the method for producing a cryopreservation container according to [15], which is formed into a bag shape with a seal.
- cryopreservation container of the present invention can be heat-sealed even at a low temperature, the container can be stably manufactured without manufacturing the noggles under severe conditions. In addition, because the heat seal strength is strong, it is possible to prevent the container from being damaged during cryopreservation. Precious biological samples can be stably stored.
- the cryopreservation container of the present invention includes at least an adhesive fluorine-containing polymer film.
- the adhesive fluorine-containing polymer film is a film formed of a polymer having at least one fluorine atom in the main chain and Z or side chain, and the film adheres to a substrate made of an organic material. It has a function.
- adheresion means that the above-mentioned adhesive fluorine-containing polymer film is bonded to the organic material by physical and Z or chemical bonding. From the viewpoint of bonding strength, chemical bonding is preferable. It is not limited to this. Examples of the chemical bond include a covalent bond, an ionic bond, a coordination bond, a hydrogen bond, and an intermolecular force. From the viewpoint of bond strength, the bond is preferably a covalent bond and an ionic bond, and more preferably a covalent bond. Is not limited to this force
- the organic material includes polyethylene, polycarbonate, polystyrene, and polyvinyl chloride.
- -Films made of cold-resistant resin such as rubber, polyacetate butyl, polyester and ultra high molecular weight polyethylene, polyimide, polytetrafluoroethylene, ethylene-tetrafluoroethylene copolymer and ethylene vinyl acetate copolymer, General purpose resin molding products such as tubes, synthetic fibers, synthetic rubbers and solid materials, and natural organic materials such as natural rubber, natural fibers, wood, papers and leathers. Includes the molecule itself. Among them, from the viewpoint of improving the cold resistance of the cryopreservation container itself, it is preferable that it can be adhered to an organic material having a function of adhering to the adhesive fluorine-containing polymer film itself and the cold resistant resin film. It is not limited to this.
- the molecular weight of the above-mentioned adhesive fluorine-containing polymer is about 1,000 to 1,000,000, preferably ⁇ is about 2,000 to 500,000 in terms of number average molecular weight. More preferred, ⁇ is a force that is about 5,000-300,000, but is not limited to this.
- the above-mentioned adhesive fluorine-containing polymer film can be produced by a person skilled in the art selecting a suitable production method in a timely manner according to the molecular structure of the adhesive fluorine-containing polymer, the glass transition temperature, the melting point, and the like.
- compression molding, injection molding, extrusion molding, ⁇ die molding, inflation Examples include sill molding and solvent casting, and compression molding is preferred from the viewpoint of molding processability, but is not limited thereto.
- the film thickness of the adhesive fluorine-containing polymer film is about 10 to: LOO / zm, preferably 10 to 50 ⁇ m, and particularly preferably 10 to 30 ⁇ m, from the viewpoint of thermal conductivity to the contents.
- the present invention is not limited to this.
- Preferred examples of the above-mentioned adhesive fluorine-containing polymer include a copolymer containing the following (A) and (B).
- the reactive functional group in the present invention is a functional group capable of adhering to the base material made of the organic material through a covalent bond, an ionic bond, a coordinate bond, a hydrogen bond, and the like.
- Examples thereof include a carboxyl group, a cyano group, a sulfonic acid group, and an epoxy group.
- a hydroxyl group that is easily activated by heat is preferable, but is not limited thereto.
- the fluorine-containing monomer is a monomer in which at least one hydrogen atom in the main chain and Z or side chain of the copolymer obtained by polymerization is substituted with fluorine.
- fluorine examples thereof include fluorine ethylenic monomers, fluorine-containing ester monomers, and fluorine-containing wholly aromatic monomers.
- a fluorine-containing ethylene monomer is preferable from the viewpoint of easy availability and molding moldability of the resulting copolymer, but is not limited thereto.
- the copolymer may be a two-component system obtained by polymerizing at least one of each of (A) and (B).
- a two-component system consisting of one (A) monomer and one (B) monomer a three-component system consisting of two (A) monomers and one (B) monomer
- Examples include a three-component system composed of one type of monomer (A) and two types of monomer (B).
- a two- or three-component system is preferable from the viewpoint of production cost, but is not limited thereto.
- Examples of the copolymer include radical copolymerization, anion copolymerization, cationic copolymerization, emulsion copolymerization, and plasma copolymerization. Depending on the monomer structure, polarity, type of solvent, etc. Those skilled in the art can select it in a timely manner. Of these, radical copolymerization is preferred from the viewpoint of ease of production! /, But is not limited to this! /.
- Examples of the form of the copolymer include a random copolymer, a block copolymer, a graft copolymer, and an alternating copolymer.
- random copolymer is preferred from the viewpoint of manufacturability, but it is not limited to this.
- the abundance ratio (copolymerization ratio) between (A) and (B) in the above copolymer is (1) from the viewpoint of the formation caloric property of the copolymer.
- A) is 1 to 2000, preferably 100 to 2000, but is not limited thereto.
- the (A) fluorine-containing monomer having no reactive functional group is a main chain and a Z or side chain of a copolymer that does not have the above-mentioned reactive functional group and is obtained by polymerization.
- a copolymer in which at least one hydrogen atom is substituted with fluorine is obtained.
- a fluorine-containing ethylenic monomer having no reactive functional group is preferred from the viewpoint of easy availability and molding processability of the resulting copolymer, but is not limited thereto.
- the (A) fluorine-containing ethylenic monomer having no reactive functional group contains at least one fluorine atom, and examples thereof include a monomer represented by the following formula (1).
- X 1 and X 2 are each a hydrogen atom or a halogen atom
- Y is a hydrogen atom, a fluorine atom, a fluorinated alkyl group having 1 to 5 carbon atoms or a fluorinated oxyalkyl group having 1 to 5 carbon atoms.
- Monomers represented by the above formula (1) include, for example, tetrafluoroethylene, vinylidene fluoride, 1,2-difunoleochloroethylene, hexafluororeopropylene, perfnoreo (bulurmethyl ether). ) And perfluoro (bulupropyl ether), preferably tetrafluoroethylene, vinylidene fluoride, 1,2-difluorochloroethylene and perfluoro (bulupropyl ether).
- perfluoro bulupropyl ether
- Tylene, vinylidene fluoride, hexafluoropropylene and perfluoro (bulupropyl ether) are preferred, but not limited thereto.
- the fluorine-containing monomer having at least one kind of reactive functional group has at least one reactive functional group described above, and the main chain of the copolymer obtained by polymerization and Z or A copolymer in which at least one hydrogen atom in the side chain is substituted with fluorine is obtained.
- a fluorine-containing ethylenic monomer having a reactive functional group is preferred from the viewpoint of easy availability and molding processability of the resulting copolymer, but is not limited thereto.
- X 1 and X 2 are each a hydrogen atom or a halogen atom
- Z is a hydroxyl group, a carboxyl group, a cyano group, a sulfonic acid group or an epoxy group
- R is a carbon number f.
- Examples of the monomer represented by the above formula (2) include perfluoro- (4 oxa 5 monohexenol) (formula (4)), perfluoro (1, 1-dihydro-6 heptenol) (formula (5)), Perfluoro (1, 1, 9, 9—Tetrahydride 2,5 Bistrifluoromethyl-3, 6-Dioxer 8-Nenol) (Formula (6)), Perfluoro (4-Oxa-5-hexenoic acid) (Formula (7)), perfluoro- (3,6-dioxa-4-trifluoromethyl-7-otatheno-tolyl) (formula (8)), perfluoro- (1,1-dihydride 3 Ntenosulfonic acid) (formula (9)) and 1,2 epoxy-perfluoro- (1,1,2 trihydr draw 6 pentene) (formula (10)), and the like.
- a preferred form of the adhesive fluorine-containing polymer in the present invention is exemplified by a copolymer represented by the following formula (3) from the viewpoint of ease of production, but is not limited thereto. It is not something.
- X 1 and X 2 are each a hydrogen atom or a halogen atom, and ⁇ 1 and ⁇ 2 are each a hydrogen atom, a fluorine atom, a fluorine-containing alkyl group having 1 to 5 carbon atoms, or a carbon atom having 1 to 5 carbon atoms.
- a fluorine alkoxy group, z is a hydroxyl group, carboxyl group, cyano group, sulfonic acid group or epoxy group
- R is a fluorine-containing alkylene group having 1 to 40 carbon atoms, f
- x 1 and x 2 are hydrogen atoms or halogen atoms, respectively, and ⁇ 1 and ⁇ 2 are Respectively a hydrogen atom, a fluorine atom, a fluorine-containing alkyl group having 1 to 5 carbon atoms or 1 carbon atom
- R is carbon number 1
- f is a fluorine-containing alkylene group having 40 to 40 carbon atoms, a fluorine-containing alkylene group having 1 to 40 carbon atoms, or a fluorine-containing alkylene group having at least one ether bond having 1 to 40 carbon atoms, and (1 + m) Zn
- polytetrafluoropolymer is preferable from the viewpoint of easy availability of monomers, ease of production, and heat seal strength.
- the adhesive fluorine-containing polymer film has an adhesive fluorine-containing polymer force having an adhesive site.
- the above-mentioned adhesive fluorine-containing polymer should have the above-mentioned reactive functional group as an adhesive site.
- the above-mentioned adhesive fluorine-containing polymer film may form an adhesive fluorine resin layer described later.
- the above-mentioned adhesive fluorine-containing polymer may constitute an adhesive fluorine resin.
- the adhesive fluorine resin layer in the present invention is made of an adhesive fluorine resin.
- the adhesive fluorine resin is preferably a fluoropolymer having an adhesive site.
- the fluoropolymer is a polymer having a fluorine-containing monomer unit derived from a fluorine-containing monomer in the main chain. Further, the fluoropolymer may or may not have a fluorine-free monomer unit derived from a fluorine-free monomer.
- the “monomer unit” for the fluoropolymer means a part of a polymer molecular structure derived from a monomer. For example, a tetrafluoroethylene unit is represented by one (CF 3 -CF 3) —.
- the fluorine-containing monomer is not particularly limited as long as it is a polymerizable compound having a fluorine atom, and examples thereof include tetrafluoroethylene [TFE], vinylidene fluoride [VdF], black trifluoroethylene [ CTFE], vinyl fluoride [VF], hexafluoropropylene [HFP], hexafluoroisobutene, perfluoro (alkyl butyl ether) [PAVE] s, the following general formula (i):
- x 3 represents a hydrogen atom or a fluorine atom
- X 4 represents a hydrogen atom, a fluorine atom or a chlorine atom
- n represents an integer of 1 to 10
- the fluorine-free monomer is not particularly limited as long as it is a compound copolymerizable with the fluorine-containing monomer and does not have a fluorine atom.
- ethylene [Et] propylene, 1-butene, 2-butene
- vinyl chloride vinylidene chloride.
- fluoropolymer examples include the following copolymer (I) and the following copolymer ( ⁇ ).
- R 2 represents CF or —OR 1
- R 1 represents a perfluoroalkyl having 3 to 5 carbon atoms, f 3 ff
- Examples of the copolymer (I) include at least a copolymer having a TFE unit of 20 to 80 mol% and an Et unit of 80 to 20 mol%.
- the mol% for each monomer unit is the adhesive site-containing monomer unit described later, out of the total number of moles of the monomer from which the monomer unit constituting the molecular chain of the copolymer is derived.
- the model number Le excluding moles of monomer was decided that derived as 100 mole 0/0, a ratio of moles of monomer each monomer unit was to derived occupied in the 100 mole 0/0 is there.
- the mol% for each monomer unit is a value obtained from an F-NMR chart.
- the copolymer (I) may have other monomer units derived from other copolymerizable monomers in addition to the TFE unit and Et unit in the main chain.
- the monomer a monomer of a type corresponding to the use of the obtained laminated film can be appropriately selected and used for copolymerization.
- R 1 represents a perfluoroalkyl group having 1 to 5 carbon atoms
- copolymer (I) is preferred in terms of heat resistance, chemical resistance, weather resistance, electrical insulation, low liquid chemical permeability, non-adhesiveness, etc.
- EtZTFEZHFP copolymer is more preferable because of its excellent properties, chemical resistance, weather resistance, electrical insulation, low chemical permeability, non-adhesiveness, low-temperature processability, transparency and the like.
- the HFP unit in the above EtZTFEZHFP copolymer preferably has a lower limit of 8 mol%, more preferably 5 to 20 mol%, and a more preferable upper limit of 17 mol%.
- the EtZTFEZHFP copolymer is one kind of the above-mentioned other monomers other than the HFP unit, as long as the EtZTFEZHFP copolymer is preferred and does not lose its properties. Or you may have two or more.
- the “adhesive site” means a functional group having affinity or reactivity with the above-mentioned organic material such as polyimide [PI] film.
- affinity means a chemical structure such as hydrogen bond, van der Waals force, etc. It means a property that shows an interaction with an organic material such as a PI film that does not lead to a change, and “reactivity” means a property that changes a chemical structure such as a functional group.
- the adhesive site is usually one that the fluoropolymer has in the main chain or side chain.
- the fluoropolymer having a site there may be only one type of adhesive site, or two or more types of adhesive sites! /.
- the “adhesive site” may be the reactive functional group described above.
- the group or bond having a carbonyl group is preferably a carbonate group, a halogenoformyl group or the like from the viewpoint of easy introduction and high reactivity.
- R is an organic group, group IA Represents an atom, a group IV atom, or a group VIIB atom.
- Examples of the organic group for R in the above formula include an alkyl group having 1 to 20 carbon atoms, an alkyl group having 2 to 20 carbon atoms having an oxygen molecule constituting an ether bond, and preferably 1 to 8 carbon atoms. Or an alkyl group having 2 to 4 carbon atoms and having an oxygen molecule constituting an ether bond.
- the halogenoformyl group is represented by COY (wherein Y represents a VIIB group atom), and -COF, -COC1, and the like are preferable.
- the number of the adhesive sites may be appropriately selected depending on the type, shape, application, required adhesive strength, difference in the type of the fluoropolymer, and the like. 10 per 6 3 ⁇ : LOOO. When counting the number of carbonyl groups, the number of the above-mentioned adhesive sites is usually 150 or more, preferably 250 or more, more preferably 300 or more per 1 ⁇ 10 6 main chain carbon atoms. .
- the number of the “adhesive sites” is measured by performing an infrared absorption spectrum analysis in accordance with the method for measuring the number of carbonyl group-containing functional groups described in International Publication No. 99Z45044. is there.
- Examples of the adhesive fluorine resin include a fluorine-containing ethylenic polymer having a carbonyl group-containing functional group described in International Publication No. 99Z45044 pamphlet.
- the adhesive fluorine resin can be usually obtained by introducing an adhesive site in the production of a fluoropolymer by polymerization, but the method for introducing the adhesive site is not particularly limited.
- the method for introducing the adhesive site is not particularly limited.
- an adhesive site-containing monomer, a fluorine-containing monomer of a type and a composition depending on the target adhesive fluorine resin, and optionally a fluorine-free monomer are known. Can be carried out by copolymerization.
- the copolymerization method is not particularly limited, and is, for example, random copolymerization in which an adhesive site-containing monomer is introduced into the system when a polymer chain is formed with another comonomer such as a fluorine-containing monomer.
- block copolymerization or graft copolymerization may be used.
- draft copolymerization include a method in which an unsaturated carboxylic acid described later is attached to a fluoropolymer.
- the "adhesive moiety-containing monomer” means a polymerizable compound having an adhesive moiety, and may or may not have a fluorine atom.
- the above-mentioned “fluorine-containing monomer” and “fluorine-free monomer” are those having the above-mentioned adhesive part.
- Examples of the adhesive part-containing monomer include, when the adhesive part is a group having a carbo group or a bond, perfluoroacrylic acid fluoride, 1 fluoroacrylic acid fluoride, acrylic acid fluoride, 1 Monomers having fluorine such as trifluoromethacrylic acid fluoride and monofluorobutenoic acid; monomers having no fluorine such as acrylic acid, methacrylic acid, acrylic acid chloride and beylene carbonate.
- Examples of the adhesive site-containing monomer further include unsaturated carboxylic acids.
- the unsaturated carboxylic acids include aliphatic unsaturated carboxylic acids and acid anhydrides thereof.
- the aliphatic unsaturated carboxylic acid may be an aliphatic unsaturated monocarboxylic acid, or may be an aliphatic unsaturated polycarboxylic acid having two or more carboxyl groups.
- aliphatic unsaturated monocarboxylic acid C3-C20 aliphatic monocarboxylic acid etc., such as propionic acid, acrylic acid, methacrylic acid, crotonic acid, those acid anhydrides, etc. are mentioned, for example.
- examples of the aliphatic unsaturated polycarboxylic acid include maleic acid, fumaric acid, mesaconic acid, citraconic acid [CAC], itaconic acid, aconitic acid, itaconic anhydride [IAH], and citraconic anhydride [CAH]. .
- diisopropyl peroxy carbonate di-n-propyl peroxydicarbonate, t-butyl peroxy isopropyl carbonate, bis (4-tert-butyl cyclohexane) are used.
- the adhesive fluorine resin has a melting point of preferably 200 ° C or lower, more preferably 180 ° C or lower, from the viewpoint of the sealing property of the obtained laminated film.
- the melting point is a temperature at the maximum value of the melting peak obtained by measuring with a differential scanning calorimeter (Seiko Co., Ltd.) at a heating rate of 10 ° CZ.
- the adhesive fluorine-containing polymer film in the present invention may be in the form of a laminated film with a film other than the adhesive fluorine-containing polymer film.
- the laminated film in the present invention is a laminate of at least an adhesive fluorine-containing polymer film and a film other than the adhesive fluorine-containing polymer film, and the adhesive fluorine-containing polymer film is at least one outermost surface.
- the number of layers may be two or more, but from the viewpoint of thermal conductivity to the contents, the force is 2 to 5 layers, preferably 2 and 3 layers, but is not limited thereto.
- the film thickness of the laminated film depends on the number of layers.
- the total film thickness is about 20 to 200 111, preferably about 20 to: LOO ⁇ m, particularly preferably about 20 to 60 ⁇ m, but is not limited thereto. It is not done.
- the thickness of the adhesive fluorine resin layer is preferably 5 to: LOO / zm, more preferably 10 ⁇ m or more and 50 ⁇ m or less.
- the adhesion strength (X) is generally 200 NZm or more, preferably 300 NZm or more, more preferably 40.
- the adhesive strength (X) is obtained by cutting a laminated film into a width of 10 mm, and using an edge of an adhesive fluororesin layer at the end and a film other than an adhesive fluorine-containing polymer film such as a PI film. This is the strength required when peeled off to make a grip and peeled 180 ° at a speed of 25 mmZ on a Tensilon universal testing machine.
- a film other than the above-mentioned adhesive fluorine-containing polymer film is not particularly limited unless it is a film having the above-mentioned adhesive fluorine-containing polymer power, but is preferably a cold-resistant resin. .
- the cold-resistant rosin refers to a rosin excellent in impact resistance at about -40 degrees or less, preferably about -80 degrees or less.
- ultra high molecular weight polyethylene, polyimide, polytetraflur Examples include fluoroethylene, ethylene-tetrafluoroethylene copolymer, and ethylene vinyl acetate copolymer.
- polyimide, polytetrafluoroethylene, and ethylene Polytetrafluoroethylene copolymer is more preferable than polyimide.
- the molecular weight of cold-resistant rosin has a number average molecular weight of about 1,000 to 1,000,000, preferably ⁇ 2,000 to 500,000, more preferably ⁇
- the force that is about 5,000-300,000 is not limited to these.
- the above impact resistance is evaluated using a free fall dart impact test method (staircase method (JIS ⁇ 7124-1)) for a resin film or sheet immediately after removal from a frozen environment.
- a free fall dart impact test method staircase method (JIS ⁇ 7124-1)
- the 50% fracture energy ( ⁇ 50) in the above-mentioned staircase method liquid nitrogen temperature
- the above is preferable.
- the polyimide is not particularly limited as long as it has a heat-resistant polymer force having an imide bond in the main chain, for example, a non-thermoplastic polyimide having only an imide bond in the main chain, a wholly aromatic polyimide, an organic solvent soluble Forces including, but not limited to, polyimide, polyetherimide, and polyimideamide.
- the cold-resistant resin film includes, for example, a force obtained by forming a cold-resistant resin by a hot melting method, an extrusion method or a compression method and a solvent casting method at a high temperature and a high pressure. Is not to be done.
- Examples of the lamination of the adhesive fluorine-containing polymer film and the film other than the adhesive fluorine-containing polymer film in the laminated film include a heat laminating method, a heat compression method, a high-frequency heating method, and a solvent casting method. .
- the thermal lamination method is preferable from the viewpoint of ease of production, but is not limited thereto. Since the adhesive fluorine-containing polymer film adheres firmly to a film other than the above-mentioned adhesive fluorine-containing polymer film, the adhesive fluorine-containing polymer film may be peeled off from the film other than the adhesive fluorine-containing polymer film. Absent.
- the temperature condition in the thermal laminating method is a force of about 200 to 300 ° C., preferably about 200 to 250 ° C., from the viewpoint of safety in production and the like, but is not limited thereto.
- the laminated film in the present invention can be prepared by laminating a film other than the adhesive fluorine-containing polymer film such as the above-mentioned PI film and an adhesive fluorine resin. Laminating of a film other than the adhesive fluorine-containing polymer film and the adhesive fluorine resin can be performed, for example, by an extrusion lamination method, or bonding with a film other than the adhesive fluorine-containing polymer film such as a PI film. It is also possible to carry out by adhering a functional fluorine resin by thermocompression bonding or the like.
- an extrusion process (a) in which the above-mentioned adhesive fluorine resin is melted and extruded onto a film other than the above-mentioned adhesive fluorine-containing polymer film such as the above-mentioned PI film (a), PI A crimping step (b) of crimping a film other than an adhesive fluorine-containing polymer film, such as a film, and an extruded adhesive fluororesin sandwiched between rolls, and a scraping step of scraping the resulting laminate (c)
- the extrusion process (a), the crimping process (b), and the scraping process (c) are performed in this order.
- the extrusion temperature in the extrusion step (a) depends on the type of film other than the adhesive fluorine-containing high molecular film such as the PI film used and the adhesive fluorine resin, the thickness of the target laminated film, etc. In general, it is preferably at least the melting point of the adhesive fluororesin used and less than the decomposition temperature in that a laminated film having a high interlayer adhesive strength can be obtained.
- the molten adhesive fluorine resin is extruded onto a film other than the adhesive fluorine-containing polymer film such as the PI film.
- the extrusion lamination is performed in an inert gas and includes an adhesive property such as a Z or PI film in that a laminated film having a high interlayer adhesive strength is obtained. It is preferable to remove water by drying or preheating a film other than the fluoropolymer film in advance.
- the extrusion lamination is present in the adhesive fluorocarbon resin by the extrusion process.
- the above-mentioned extrusion lamination is performed in an inert gas, and a film other than an adhesive fluorine-containing high molecular film such as a Z or PI film. It is considered that the above adhesiveness can be sufficiently exhibited when moisture is removed by drying or preheating the material in advance.
- the process conditions other than the above-described extrusion step (a) in the above-mentioned extrusion lamination are the types of films other than the adhesive fluorine-containing polymer film such as the PI film to be used, and the types of adhesive fluorine resin. Depending on the thickness of the laminated film, etc., it can be appropriately set according to a known method.
- the thermocompression bonding is preferably performed at a temperature of 120 to 300 ° C.
- the temperature is more preferably V lower limit of 140 ° C and more preferably upper limit of 280 ° C.
- the films other than the adhesive fluorine-containing polymer film such as the above-mentioned PI film are laminated by thermocompression bonding or the like, they may be preheated prior to lamination or pre-dried. Also, when bonding each layer by thermocompression bonding, etc., in order to improve interlayer adhesion, it is possible to heat and age after bonding!
- the heating for the aging is preferably performed at 200 to 280 ° C.
- the laminated film is formed into a container or bag shape by a heat sealing method or the like. Specifically, two laminated films are stacked so that the adhesive fluorine-containing polymer films are in contact with each other, and heat sealing is performed.
- the inner volume of the container is generally about 2 to 200 ml, but is not limited to this.
- the width of the heat seal is not limited to this, which is about 2 to 20 mm, preferably about 5 to 15 mm, from the viewpoint of the sealing strength between the laminated films.
- the heat seal temperature is about 180 to 250 ° C, preferably about 200 to 220 ° C, from the viewpoint of the sealing strength between the laminated films.
- General-purpose fluororesin films cannot be sealed at temperatures as low as 180-250 ° C. In other words, the present invention Since the adhesive fluorine-containing polymer film has good heat sealability at low temperatures, the cost in the production process is also low.
- the cryopreservation container of the present invention contains, for example, blood components such as red blood cells, platelets, and plasma, and biological samples such as bone marrow fluid, other body fluids, and cell suspensions, and the contents when the cryopreservation container is damaged. It may be further packaged to protect materials and prevent liquid nitrogen from entering the cryopreservation container. As these packages, packages made of perfluoroethylenepropene copolymer are generally used, but are not limited thereto. At this time, the air between the cryopreservation container and the package can be easily degassed by using, for example, an auxiliary tool disclosed in Japanese Patent Application Laid-Open No. 2000-185716. It is not limited.
- the cryopreservation container of the present invention can be produced by forming the laminated film into a container or bag shape by a heat seal method or the like.
- the cryopreservation container uses a laminated film in which an adhesive fluoropolymer film is present on at least one outermost surface as the above-mentioned laminated film
- the cryopreservation container contains adhesiveness on at least one outermost surface.
- the container can be a container having a fluoropolymer film, and is preferably a container having an adhesive fluorine-containing polymer film at least on the outermost surface inside the container.
- the cryopreservation container of the present invention is capable of withstanding even at extremely low temperatures of -80 to 196 ° C. Forces Blood components such as erythrocytes, platelets and plasma, bone marrow fluid, other body fluids and cell suspensions In the case of actual storage, it is preferable to cool gradually in order not to damage these tissues.
- the power is not limited to this, for example, a method of once cooling it to about ⁇ 80 degrees with a deep freezer or the like and then storing it in liquid nitrogen.
- a heating means such as a 37-40 ° C. warm bath is not limited thereto.
- a commercially available storage solution can be appropriately used.
- the storage solution include DMEM medium, RPMY1640 medium, 199 medium, and phosphate buffer.
- DMEM medium Preferably, about 0.5 to 2% by volume of albumin may be added.
- dimethyl sulfoxide (DMSO) is used as a freezing protection agent. A final concentration of about 5-20% by volume may be added.
- Eurocollins solution and UW solution can be used.
- dimethyl sulfoxide (DMSO) may be added as a frost damage protective agent to a final concentration of about 5 to 20% by volume.
- the selection and preparation of these preservation solutions are not particularly limited because they can be appropriately selected by those skilled in the art.
- Examples of the method for freezing the cryopreservation container of the present invention containing or storing a biological sample include a method of freezing the cryopreservation container containing or storing a biological sample at 0 ° C or lower.
- a method of freezing at 80 ° C. or lower is preferable.
- the cryopreservation container is gradually cooled to a desired temperature and frozen in order not to damage the biological sample.
- Examples of such a freezing method include a method in which the cryopreservation container is once cooled to about 80 ° C. with a deep freezer (freezer) and then immersed in liquid nitrogen.
- the cryopreservation container may contain the above-described storage solution as necessary.
- the above cryopreservation container is usually kept frozen after being frozen by the above method.
- the cryopreservation container of the present invention has the above-described configuration, it does not break even at an extremely low temperature such as liquid nitrogen temperature (196 ° C), and the sealing performance at the sealed portion does not deteriorate. It can prevent the contamination and spillage of the contents that liquid refrigerant such as liquid nitrogen does not enter during freezing storage, and exhibits excellent protection performance.
- cryopreservation container is resistant to temperatures as low as the above-mentioned cryogenic temperatures as long as it is less than the melting point of the adhesive fluorocoagulant used. Therefore, even when the temperature is changed to a room temperature after being placed at the cryogenic temperature, there is no breakage and deterioration of the sealing performance at the sealing portion.
- the cryopreservation container of the present invention exhibits the above-mentioned excellent effects.
- (1 ) PI has extremely low temperature resistance that can maintain the shape of the molded body even at extremely low temperatures such as liquid nitrogen temperature.
- ( 3) The PI film and the adhesive fluororesin layer can be directly bonded without using an adhesive, and there is a problem when using an adhesive, that is, the adhesive layer is at a liquid nitrogen temperature.
- a laminated film formed by laminating a PI film and an adhesive fluororesin layer forms a cryopreservation container by thermally fusing the adhesive fluororesin layers to each other. It is considered that the properties of being excellent in adhesion between each other and reliable in sealing properties are synergistically exhibited.
- the cryopreservation container of the present invention can be suitably used as a cryopreservation container for biological samples.
- the cryopreservation container of the present invention is a container that can seal biological samples such as blood components, cells, tissues, organs, viruses, bacteria, sperm, eggs, fertilized eggs, and the like.
- Examples of the blood components include whole blood, red blood cells, white blood cells, plasma, platelets, and platelet-rich plasma.
- the cells include hematopoietic stem cells, ES cells, mesenchymal stem cells, skeletal mononuclear cells, rare cells such as sperm cells and egg cells, and general cells such as nerve cells, epithelial cells, fibroblasts, etc. Is mentioned.
- tissue as various tissues such as tendons, nerves, ligaments, esophagus, trachea, and spleen, as well as membrane tissues and organs such as mucosal epithelial tissue, corneal epithelial tissue and cultured corneal tissue
- examples include the spleen, heart, lungs, liver and kidneys.
- viruses include hepatitis B virus, hepatitis C virus, coronavirus, and mosaic virus.
- the bacteria include tuberculosis bacteria, Haemophilus influenzae, Escherichia coli, Staphylococcus aureus, hemolyzed staphylococci, and Klebsiella pneumoniae.
- sperm, ovum and fertilized egg are mentioned in the field of infertility treatment, for example.
- These stored blood or blood components, cells containing rare cells, and other biological tissues are selected according to the purpose of the operator and are not particularly limited.
- biological tissue examples include biological fluids (blood, cerebrospinal fluid, lymph, etc.) and components thereof (red blood cells, white blood cells, platelets, plasma, serum, etc.), and biological tissues (blood vessels, cornea, Meniscus, brain tissue, skin, subcutaneous tissue, epithelial tissue, bone tissue, muscle tissue, etc.), organs (eye, lung, kidney, heart, liver, spleen, spleen, digestive tract, bladder, ovary, testis, etc.), various Cells (such as cord blood, hematopoietic stem cells such as peripheral blood-derived hematopoietic stem cells, bone marrow cells, hepatocytes, spleen cells and brain cells) Various organ cells, nerve cells, sperm, egg cells, fertilized eggs, embryonic stem cells (ES cells), cancer cells for research and treatment, cultured cells, stem cells, embryo cells, etc.).
- biological fluids blood, cerebrospinal fluid, lymph, etc.
- components thereof red blood cells, white blood cells, platelets, plasma
- Examples of the biological sample include human biological tissues and genetic related substances, as well as biological tissues and genetic related substances of animals including small animals such as small experimental animals; microorganisms, bacteria, and genetic related substances thereof. These include, for example, those used in the research field.
- Examples of the biological sample also include livestock / animal biological tissues and genetic materials, and examples thereof include those used in the agricultural field such as research, culture, cultivation, and horticulture.
- Examples of the biological sample also include plant seeds, pollen, cultured cells, shoot apical cells, and genetic materials.
- biological sample examples include biological tissues such as marine algae and fish and genetic related substances, and examples thereof include those used in the field of fisheries such as research.
- Examples of the above-mentioned gene-related substances include DNA, host, vector and the like.
- the biological sample is, for example, for medical use; for research and development in the fields of agriculture, forestry, fisheries, horticulture, etc .; for animal treatment, fertility treatment, etc. in the pet industry and animal industry. It can be used for related purposes, cloning techniques, etc.
- cryopreservation container of the present invention can be used in various fields such as medicine; research; agriculture such as livestock and horticulture;
- polyimide film 8-component random copolymer film (hereinafter referred to as inner layer fluororesin film and outer layer fluororesin film, respectively)
- inner layer fluororesin film and outer layer fluororesin film Two-layer and three-layer films were prepared by the heat laminating method. Two sheets of the above film cut to a size of 180 x 100 mm are stacked so that the inner fluororesin film is in contact with each other, and the edge 10 mm is heat-sealed by the heat seal method to form a cryopreservation container. Created. Table 1 shows the film thickness of each film layer.
- the copolymer composition ratio of the above three-component random copolymer film is as follows: perfluoro (1, 1, 9, 9—tetrahydride 1, 2, 5-bistrifluoromethyl 1, 3, 6—dioxa 8—nonenor )
- perfluoro 1, 9, 9—tetrahydride 1, 2, 5-bistrifluoromethyl 1, 3, 6—dioxa 8—nonenor
- monomer unit 1 the total number of polytetrafluoroethylene monomer units and perfluoro (bulupropyl ether) monomer units was 99.
- the copolymer composition ratio was measured by 19 F-NMR.
- Comparative Example 1 Comparative cryopreservation container 1
- a commercially available cryopreservation container (manufactured by BAXER) made of an ethylene-vinyl acetate copolymer was used.
- Comparative Example 2 Comparative cryopreservation container 2
- a commercially available cryopreservation container made of polyethylene (CharterMed) was used.
- the inside temperature was kept at 35 ° C and the stirring speed was kept at 200 rpm. Further, tetrafluoroethylene was injected into 7.25 kgZcm 2 G, and then ethylene was injected into 8 kgZcm 2 G.
- the polymerization was conducted for a total of 32 hours. After polymerization is complete, the contents are recovered, washed with water, and contacted with powder. 95 kg of adhesive fluorocoagulant was obtained.
- N 500AW / ⁇ df
- the temperature was measured at a rate of temperature increase of 10 ° CZ, and the temperature at the maximum value of the melting peak obtained was taken as the melting point.
- Example 9 A T-die is connected to a single-screw extruder with a cylinder diameter of 90 mm using the adhesive fluorine resin obtained from the synthesis example, the cylinder temperature is 170 to 230 ° C, the die temperature is 230 ° C, the screw An adhesive fluororesin film (thickness: 25 m) was molded under the condition of the number of revolutions lOrpm.
- the adhesive fluororesin film obtained and a polyimide film product name: Kapton 100H, manufactured by Toray DuPont, thickness: 25 ⁇ m
- Kapton 100H manufactured by Toray DuPont, thickness: 25 ⁇ m
- a laminated film (length 20 m ⁇ width 200 mm ⁇ total thickness 50 ⁇ , hereinafter referred to as a long film) was obtained.
- the resulting laminated film (fluorine-resin layer thickness: 25 m, polyimide layer thickness: 25 / zm) was cut into a strip of 100 mm in the length direction and 10 mm in the width direction, and its edges Fluorine resin layer and polyimide layer were peeled off using a blade to make a margin, and measured using a Tensilon universal testing machine (Orientec Co., Ltd.) 180 ° peeled at a rate of 25 mmZ, measured at 400 NZm. there were.
- cryopreservation container of the present invention can sufficiently cope with liquid nitrogen immersion.
- cryopreservation containers prepared in Examples 1 to 9 and the cryopreservation containers of Comparative Examples 1 and 2 were each filled with 80 ml of a dimethyl sulfoxide (DMSO) 10% (vZv) aqueous solution, and the air was sufficiently evacuated. Housed in an aluminum case. Dee container stored in aluminum case It was left to stand at 80 ° C for 4 hours in a freezer (freezer) and frozen. The frozen container was then transferred into liquid nitrogen and stored for 1 week. The stored container was also taken out of the aluminum case, and thawed in a 37-40 ° C warm bath, and the container was visually inspected for damage and liquid nitrogen contamination.
- DMSO dimethyl sulfoxide
- Table 2 shows the results of the experiment. While Comparative Example 1 was damaged by 20% and Comparative Example 2 was broken by 10%, the cryopreservation container of the present invention had a huge number of tests of 30 pieces, but it was not damaged. I got it.
- Example 9 Each of the cryopreservation container and the cryopreservation container of Comparative Example 1 were filled with 80 ml of a cell suspension of dimethylsulfoxide (DMSO) 10% (v / v), fully evacuated, and then made of aluminum. Stored in a case. The container housed in the aluminum case was frozen at 80 ° C for 4 hours using a deep freezer. The frozen container was then transferred into liquid nitrogen and stored for 1 week. The stored container was also taken out of the aluminum case, and thawed in a 37-40 ° C warm bath, and visually inspected the container for damage and liquid nitrogen contamination. Each test was conducted 5 times.
- DMSO dimethylsulfoxide
- the cryopreservation container of the present invention makes it possible to store blood, rare cells, and biological tissues without damage in a cryogenic environment.
- the film thickness is relatively thin, the thermal conductivity to the contents of the cryopreservation container is not reduced.
- the sealability by heat sealing after storing the cryopreservation container is very good, it is possible to prevent the inside of the liquid nitrogen from being mixed, and contamination and thawing by bacteria or viruses in the liquid nitrogen. It is possible to prevent the cryopreservation container from rupturing due to the expansion of mixed liquid nitrogen.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Environmental Sciences (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Dentistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Laminated Bodies (AREA)
- Packages (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Wrappers (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Bag Frames (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
La présente invention concerne un récipient de stockage par congélation qui est tellement résistant à la congélation qu’il ne se brise pas, même à -196 °C, ce qui est la température de l’azote liquide. Il peut être moulé avec une épaisseur de paroi relativement petite et présente une excellente aptitude au thermoscellage. Un récipient de stockage par congélation comprenant un film en polymère fluoré adhésif est proposé. Ce récipient de stockage par congélation permet de stocker du sang, des cellules ou un tissu biologique dans un environnement à température extrêmement basse, sans se briser. Le récipient peut empêcher que l’azote liquide rentre à l’intérieur. Il peut prévenir la contamination par les bactéries, les virus ou analogues se trouvant dans l’azote liquide. En outre, il n’est pas concerné par le problème selon lequel un récipient de stockage par congélation se brise lors de la décongélation en raison de la dilatation de l’azote liquide qui est entré dans le récipient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007509372A JP5090902B2 (ja) | 2005-03-25 | 2006-03-27 | 凍結保存容器およびその製造方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005-090010 | 2005-03-25 | ||
JP2005090010 | 2005-03-25 | ||
JP2005-128458 | 2005-04-26 | ||
JP2005128458 | 2005-04-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006101237A1 true WO2006101237A1 (fr) | 2006-09-28 |
Family
ID=37023883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/306183 WO2006101237A1 (fr) | 2005-03-25 | 2006-03-27 | Recipient de stockage par congelation et procede pour sa fabrication |
Country Status (3)
Country | Link |
---|---|
JP (2) | JP5090902B2 (fr) |
TW (1) | TW200708305A (fr) |
WO (1) | WO2006101237A1 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015133480A (ja) * | 2013-12-10 | 2015-07-23 | 旭硝子株式会社 | カバーレイ用接着フィルム、カバーレイ、配線板、及び電子機器の製造方法 |
WO2017061097A1 (fr) * | 2015-10-05 | 2017-04-13 | 山下 直樹 | Autocollant d'affichage de récipient de culture |
JPWO2016088723A1 (ja) * | 2014-12-02 | 2017-09-14 | 株式会社北里バイオファルマ | 採取生体組織凍結保存用具および採取組織片凍結方法 |
US12239127B2 (en) | 2021-07-28 | 2025-03-04 | Sartorius Stedim North America Inc. | Thermal capacitors, systems, and methods for rapid freezing or heating of biological materials |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102311221B1 (ko) * | 2014-04-28 | 2021-10-13 | 삼성전자주식회사 | 오브젝트 운용 방법 및 이를 지원하는 전자 장치 |
JP2018011809A (ja) * | 2016-07-22 | 2018-01-25 | 大日本印刷株式会社 | 細胞凍結保存容器 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54144275A (en) * | 1978-04-28 | 1979-11-10 | Toppan Printing Co Ltd | Container resistant to heat and very low temperature |
JPS5967960A (ja) * | 1982-10-09 | 1984-04-17 | テルモ株式会社 | 血液保存容器用材料の製造方法 |
JPH06263951A (ja) * | 1993-03-16 | 1994-09-20 | Asahi Glass Co Ltd | 加硫可能なフッ素ゴム組成物 |
JPH06271733A (ja) * | 1993-03-17 | 1994-09-27 | Asahi Glass Co Ltd | 加硫可能な弗素ゴム組成物 |
WO1998046426A1 (fr) * | 1997-04-15 | 1998-10-22 | Daikin Industries, Ltd. | Materiau composite anti-corrosion |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE340144B (fr) * | 1967-02-01 | 1971-11-08 | Investrop Ag | |
US5250044A (en) * | 1990-02-06 | 1993-10-05 | Du Pont Merck Pharmaceutical Company | Blood cryopreservation container |
EP1160270A4 (fr) * | 1998-10-06 | 2003-03-19 | Daikin Ind Ltd | Article moule en resine fluoree non perfluoree a thermoscellabilite sous faible temperature |
JPWO2004018201A1 (ja) * | 2002-08-21 | 2005-12-08 | ダイキン工業株式会社 | 含フッ素積層体及び含フッ素積層体製造方法 |
-
2006
- 2006-03-24 TW TW095110641A patent/TW200708305A/zh unknown
- 2006-03-27 JP JP2007509372A patent/JP5090902B2/ja active Active
- 2006-03-27 WO PCT/JP2006/306183 patent/WO2006101237A1/fr active Application Filing
-
2012
- 2012-06-06 JP JP2012129301A patent/JP5548732B2/ja active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54144275A (en) * | 1978-04-28 | 1979-11-10 | Toppan Printing Co Ltd | Container resistant to heat and very low temperature |
JPS5967960A (ja) * | 1982-10-09 | 1984-04-17 | テルモ株式会社 | 血液保存容器用材料の製造方法 |
JPH06263951A (ja) * | 1993-03-16 | 1994-09-20 | Asahi Glass Co Ltd | 加硫可能なフッ素ゴム組成物 |
JPH06271733A (ja) * | 1993-03-17 | 1994-09-27 | Asahi Glass Co Ltd | 加硫可能な弗素ゴム組成物 |
WO1998046426A1 (fr) * | 1997-04-15 | 1998-10-22 | Daikin Industries, Ltd. | Materiau composite anti-corrosion |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015133480A (ja) * | 2013-12-10 | 2015-07-23 | 旭硝子株式会社 | カバーレイ用接着フィルム、カバーレイ、配線板、及び電子機器の製造方法 |
JPWO2016088723A1 (ja) * | 2014-12-02 | 2017-09-14 | 株式会社北里バイオファルマ | 採取生体組織凍結保存用具および採取組織片凍結方法 |
WO2017061097A1 (fr) * | 2015-10-05 | 2017-04-13 | 山下 直樹 | Autocollant d'affichage de récipient de culture |
US12239127B2 (en) | 2021-07-28 | 2025-03-04 | Sartorius Stedim North America Inc. | Thermal capacitors, systems, and methods for rapid freezing or heating of biological materials |
Also Published As
Publication number | Publication date |
---|---|
JP5548732B2 (ja) | 2014-07-16 |
TW200708305A (en) | 2007-03-01 |
JP5090902B2 (ja) | 2012-12-05 |
JP2012236035A (ja) | 2012-12-06 |
JPWO2006101237A1 (ja) | 2008-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5090903B2 (ja) | 凍結保存容器の包装体およびその製造方法 | |
JP5548732B2 (ja) | 凍結保存容器およびその製造方法 | |
JP4016044B2 (ja) | ハロゲンを含まない、レトルト可能な多層バリアーフィルム | |
EP0098312B1 (fr) | Récipient résistant à des températures extrêment basses | |
US5998019A (en) | Multi-layered polymer structure for medical products | |
IE53282B1 (en) | Platelet storage container | |
JP2008195443A (ja) | 冷凍保存容器 | |
JP2007161307A (ja) | 凍結保存容器、その製造方法並びに生物試料の凍結保存方法 | |
US6071690A (en) | Ionomeric modified poly-ether-ester plastic container for cryogenic fluids | |
JP5028853B2 (ja) | 加熱処理用袋状物 | |
JP5109631B2 (ja) | 凍結保存用バッグ及び凍結保存方法 | |
US20050129887A1 (en) | Medical freezer bag | |
JPH111247A (ja) | 凍結保存用バッグ | |
JP3941091B2 (ja) | 冷凍保存方法 | |
JPS6136941B2 (fr) | ||
JPS6159738B2 (fr) | ||
AU2010201489B2 (en) | High abuse heat shrinkable film | |
US10486403B2 (en) | Ovenable thermoformable film | |
JPH0613714Y2 (ja) | 冷凍バツグ | |
JP2024002939A (ja) | 細胞培養容器用シーラントフィルム | |
EP2737999A1 (fr) | Film thermorétractable à forte résistance contre les mauvais traitements | |
JPS6339258B2 (fr) | ||
JPS6254730A (ja) | 包装体 | |
JPH03295557A (ja) | 冷凍バッグ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007509372 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06730131 Country of ref document: EP Kind code of ref document: A1 |